856705 | 16:0 Lyso PE

1-palmitoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine


Powder

Size SKU Packaging Price
25mg 856705P-25mg 856705P-25mg 1 x 25mg $190.00
200mg 856705P-200mg 856705P-200mg 1 x 200mg $410.00
Base Price: ${originalprice|money}
Custom Packaging: (${concentration} @$4.00/ea. + $100) ${custompackagingtotal|money}
Packaging: ${concentration}
Item Total: ${totalprice|money}
(Sales Tax may apply)
Please select an option above.
${sku} - ${concentration}

16:0 Lyso PE

16:0 Lyso PE

1-palmitoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine

Hygroscopic
Yes
Light Sensitive
No
Molecular Formula
C21H44NO7P
Percent Composition
C 55.61%, H 9.78%, N 3.09%, O 24.69%, P 6.83%
Purity
>99% LPE; may contain up to 10% of the 2-LPE isomer
Stability
1 Years
Storage Temperature
-20°C
CAS Number
53862-35-4
CAS Registry Number is a Registered Trademark of the American Chemical Society
Formula Weight
453.550
Exact Mass
453.286
Synonyms
1-hexadecanoyl-sn-glycero-3-phosphoethanolamine
PE(16:0/0:0)
110698

Shima Y, Morita D, Mizutani T, Mori N, Mikami B, Sugita M. Crystal structures of lysophospholipid-bound MHC class I molecules. J Biol Chem. 2020 May 15;295(20):6983-6991. doi: 10.1074/jbc.RA119.011932. Epub 2020 Apr 8. PMID: 32269076.

PubMed ID: 32269076

Shi Q, Jin S, Xiang X, Tian J, Huang R, Li S, Chen C, Xu H, Song C. The metabolic change in serum lysoglycerophospholipids intervened by triterpenoid saponins from Kuding tea on hyperlipidemic mice. Food Funct. 2019 Dec 11;10(12):7782-7792. doi: 10.1039/c9fo02142f.

PubMed ID: 31782452

Daniel J. Stephenson, H. Patrick MacKnight, L. Alexis Hoeferlin, Margaret A. Park, Jeremy C. Allegood, Christopher L. Cardona, and Charles E. Chalfant. A rapid and adaptable lipidomics method for quantitative UPLC-mass spectrometric analysis of phosphatidylethanolamine and phosphatidylcholine in vitro, and in cells. Anal. Methods, 2019,11, 1765-1776. doi: 10.1039/C9AY00052F


Yan Y, Du Z, Chen C, Li J, Xiong X, Zhang Y, Jiang H. Lysophospholipid profiles of apolipoprotein E-deficient mice reveal potential lipid biomarkers associated with atherosclerosis progression using validated UPLC-QTRAP-MS/MS-based lipidomics approach. J Pharm Biomed Anal. 2019 Jul 15;171:148-157. doi: 10.1016/j.jpba.2019.03.062. Epub 2019 Apr 5.

PubMed ID: 30999225

Zhao Q, Zhang T, Xiao XR, Huang JF, Wang Y, Gonzalez FJ, Li F. Impaired clearance of sunitinib leads to metabolic disorders and hepatotoxicity. Br J Pharmacol. 2019 Mar 15. doi: 10.1111/bph.14664. [Epub ahead of print]

PubMed ID: 30875096

Sonti S, Tolia M, Duclos RI Jr, Loring RH, Gatley SJ. Metabolic studies of synaptamide in an immortalized dopaminergic cell line. Prostaglandins Other Lipid Mediat. 2019 Apr;141:25-33. doi: 10.1016/j.prostaglandins.2019.02.002. Epub 2019 Feb 11.

PubMed ID: 30763677